U.S. Media Stock News

Vicor stock has delivered a very strong 320.2% return over the past year, yet the current checks on valuation suggest a company that no longer looks obviously cheap. The Discounted Cash Flow (DCF) intrinsic value estimate points to pricing that is roughly in line with fundamentals, while the broader valuation score leans more cautious. Over the past 12 months, Vicor has returned 320.2%, which puts extra focus on whether recent gains are already pricing in a lot of good news. Growing demand...

Some CSX Corporation ( NASDAQ:CSX ) shareholders may be a little concerned to see that the VP & Chief Accounting...

Looking at Carriage Services, Inc.'s ( NYSE:CSV ) insider transactions over the last year, we can see that insiders...

We wouldn't blame The Progressive Corporation ( NYSE:PGR ) shareholders if they were a little worried about the fact...

AMREP Corporation ( NYSE:AXR ), might not be a large cap stock, but it saw significant share price movement during...

Some Roper Technologies, Inc. ( NASDAQ:ROP ) shareholders may be a little concerned to see that the Independent...

In late July 2026, Mercury Insurance released its annual list of the 10 most affordable new 2026 model year SUVs to insure, underscoring how vehicle choice can meaningfully affect long-term insurance costs. Analyst commentary around the same time characterized Mercury General as a strong growth candidate with favourable earnings prospects, drawing attention to how shifting expectations and estimate revisions can reshape perceptions of an insurer’s future earnings power. We’ll now examine...

Carvana (CVNA) has expanded its same day vehicle delivery service to the greater Fort Myers area, giving local customers faster access to online purchases and same day options for selling or trading in vehicles. See our latest analysis for Carvana. The latest product rollout comes after a mixed period for Carvana’s stock, with the 1 day share price return of 3.17% and 1 month share price return of 5.97% contrasting with a year to date decline of 17.46% and a much stronger 3 year total...

Hexcel’s share price has more than doubled over the past five years, yet valuation checks send mixed signals, with a Discounted Cash Flow (DCF) intrinsic value suggesting the stock trades below its estimated worth while market multiples point to a richer price tag. Hexcel has returned 105.9% over five years, which puts extra focus on whether the current price still offers a margin between market value and the intrinsic estimate. The recent NCAMP qualification of the HexPly M91 composite...

Conagra Brands stock has fallen about 43.8% over the past three years, yet on Simply Wall St's checks it still screens as relatively cheap overall, while the share price now looks closer to fair on standard market multiples. With management resetting the dividend and committing extra supply chain investment, investors are weighing whether the current price fairly reflects those trade offs. The roughly 43.8% share price decline over three years points to weak recent returns and a market that...

Ascendis Pharma (NasdaqGS:ASND) has drawn fresh investor attention after recent trading left the stock around $254.44, with short term returns mixed over the past week, month and past three months. See our latest analysis for Ascendis Pharma. Over a longer stretch, Ascendis Pharma has seen a 10.93% 90 day share price return and a 3.69% year to date share price return. The recent 30 day decline of 3.51% suggests some of that momentum has cooled even as the stock holds near US$254.44. If this...

ScanSource stock performance snapshot after recent move ScanSource (SCSC) has drawn fresh attention after a recent share price move, with the stock last closing at US$57.27. Investors are assessing how this aligns with the company’s value score of 3 and recent return profile. See our latest analysis for ScanSource. The recent 1-day share price return of 2.97% extends a strong run for ScanSource, with a 30-day share price return of 12.58% and a 5-year total shareholder return of 108.03%. This...

Netflix stock has fallen sharply over the past year, yet several valuation checks still point to the shares trading below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) approach and earnings multiples. With the next set of results expected soon and sentiment pulled around by mixed headlines, investors are weighing whether recent weakness already reflects the key risks. Over the past 3 years Netflix has returned about 65%, which suggests that longer term holders are...

Mirion Technologies (MIR) has drawn fresh attention after reporting second quarter 2026 results and reaffirming full year revenue growth guidance of about 22% to 24%, supported by foreign exchange and acquisition related tailwinds. See our latest analysis for Mirion Technologies. Despite reaffirmed guidance and solid top line progress, Mirion Technologies’ recent share price performance has been weak, with the stock down 29.54% on a year to date basis while the 3 year total shareholder return...

Post Holdings (POST) is back in focus after recent share price moves, with the stock last closing at $94.32. Investors are reassessing the consumer packaged goods group and its mix across cereal, pet food and refrigerated products. See our latest analysis for Post Holdings. The recent 1 day share price return of 3.3% and 7 day return of 6.7% put Post Holdings on investors’ radar again, although the share price is still down 5.3% year to date and the 1 year total shareholder return has...

VICI Properties Inc. recently entered the spotlight ahead of its now-reported second-quarter 2026 results, with analysts previously expecting growth in revenues and adjusted funds from operations (AFFO) per share supported by its long-term triple-net leases with established gaming and hospitality operators. At the same time, the company’s substantial debt load and associated interest costs were seen as a potential drag on performance, highlighting the tension between stable lease income and...

Palantir Technologies has delivered a very large 3 year return, yet its valuation picture is split. The Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable discount to the current share price, while traditional multiples and the broader valuation checks suggest the stock is not obviously cheap. Palantir Technologies has returned a very large multiple over the past 3 years, which puts extra focus on whether the current price still leaves enough room for future cash flows...

In July 2026, Orchid Island Capital, Inc. reported a turnaround in performance for the second quarter and first half of 2026, posting net income of US$89.19 million for the quarter and US$69.24 million for the six months ended June 30, with basic earnings per share from continuing operations moving into positive territory versus losses a year earlier. Over the same period, the company completed a long-running share repurchase plan initiated in 2015, buying back more than one quarter of its...

Karman Holdings stock has risen in the short term but is still down sharply year to date, and the valuation checks currently lean expensive rather than pointing to a clear bargain. Year to date, Karman Holdings shares have fallen 35.5%, which puts recent gains into the context of a still weak overall return profile. The planned acquisition of Walker Precision Engineering can support expectations for growth in the European missile market. However, integration execution and capital allocation...

Block stock has staged a recovery in the short term. However, after a roughly 69.2% decline over the past 5 years, its valuation signals are split, with the Excess Returns intrinsic value estimate pointing to some upside while traditional earnings multiples lean expensive and the broader checks are cautious. Block shares have fallen about 69.2% over the past 5 years, so the long term track record is still weak even after recent gains. Recent positive analyst ratings and revenue growth...

TG Therapeutics recently reported that Briumvi exceeded expectations in clinical trials and that it has begun a Phase 2 study in treatment-resistant schizophrenia, developments that have drawn increased attention from investors and analysts. These clinical advances, combined with analysts’ more optimistic earnings projections, highlight how a single therapy platform may be shaping the company’s overall growth prospects. We’ll now examine how Briumvi’s stronger-than-expected trial results...

The upcoming Q2 earnings report for Mosaic (MOS) on August 4 is in focus. The market expects earnings to decline even as revenues are projected higher, and recent estimate cuts highlight the uncertainty around this release. See our latest analysis for Mosaic. The recent 1 day share price return of 3.31% and 7 day share price return of 5.05% suggest investors are positioning ahead of Mosaic's Q2 report. However, the year to date share price return is down 7.75% and the 1 year total shareholder...

Rambus stock is absorbing a sharp hit, with shares down about 9% from the prior close near US$96 as investors react to the latest earnings. That price move sits against a quarter that delivered record Q2 revenue of US$207.4m and non GAAP earnings per share of US$0.77, both ahead of management guidance. The short term tape looks rough. The longer term story still turns on whether high margin memory interface chips and intellectual property tied to artificial intelligence data centers can...

Recent momentum and leasing progress put Macerich in focus Macerich (MAC) is back on investor radar after a period of strong technical momentum, with the stock up nearly 50% over the past year and on track to reach 85% of its leasing target by midyear. See our latest analysis for Macerich. The recent leasing progress and mixed analyst sentiment appear to sit alongside strong price momentum, with Macerich’s 90 day share price return of 21.49% and 1 year total shareholder return of 59.49%...